Parison Amy 4

What Happened
Amy Parison, Chief Financial Officer of Editas Medicine (EDIT), received a grant of 292,856 derivative stock awards (reported as an option grant) on March 12, 2026. The filing reports a $0.00 price per share for this award; no cash was paid. This is a compensation award (not a market purchase or sale).

Key Details

• Transaction date: 2026-03-12; Form 4 filed: 2026-03-16.
• Award size: 292,856 shares (derivative option); reported price: $0.00 per share.
• Vesting: The option vests in equal monthly installments over four years, beginning April 12, 2026 and ending March 12, 2030 (see footnote).
• Shares owned after transaction: not specified in the provided filing summary.
• No indication in the filing that shares were exercised or sold; this is a grant of an equity award for compensation.

Context
This was a compensation grant to an executive and should be viewed as part of routine equity-based pay rather than an open-market purchase or sale. For derivatives/options, value realization depends on future vesting and any exercise terms; this grant vests monthly over four years. Investors may check the full Form 4 for complete ownership totals and any additional terms.